Lifecome Biochemistry Co.,Ltd. (002868.SZ)
CNY 15.88
(-2.87%)
CNY 15.88
(-2.87%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -127.92 Million CNY | -1129.08% |
| 2022 | -53.71 Million CNY | -133.3% |
| 2021 | 12.65 Million CNY | -84.9% |
| 2020 | 79.87 Million CNY | -14.49% |
| 2019 | 95.75 Million CNY | -18.04% |
| 2018 | 91.74 Million CNY | -8.84% |
| 2017 | 128.83 Million CNY | -8.32% |
| 2016 | 113.43 Million CNY | 8.95% |
| 2015 | 118.54 Million CNY | 74.21% |
| 2014 | 74.03 Million CNY | 76.04% |
| 2013 | 41.8 Million CNY | -37.18% |
| 2012 | 63.07 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -30.36 Million CNY | -206.1% |
| 2024 Q3 | -61 Million CNY | -69.48% |
| 2024 Q1 | -11.75 Million CNY | 90.96% |
| 2023 Q4 | -82.87 Million CNY | -67.68% |
| 2023 Q1 | 17.49 Million CNY | 232.49% |
| 2023 FY | - CNY | -1129.08% |
| 2023 Q2 | -8.04 Million CNY | -145.98% |
| 2023 Q3 | -49.42 Million CNY | -514.46% |
| 2022 Q3 | -30.51 Million CNY | -113.16% |
| 2022 Q2 | -14.31 Million CNY | -38.21% |
| 2022 Q4 | -13.2 Million CNY | 56.72% |
| 2022 FY | - CNY | -133.3% |
| 2022 Q1 | -10.35 Million CNY | 53.55% |
| 2021 Q2 | 7.3 Million CNY | 91.39% |
| 2021 Q3 | -10.12 Million CNY | -238.54% |
| 2021 Q4 | -22.29 Million CNY | -120.27% |
| 2021 FY | - CNY | -84.9% |
| 2021 Q1 | 3.81 Million CNY | 280.18% |
| 2020 Q2 | 29.79 Million CNY | 81.18% |
| 2020 Q1 | 16.44 Million CNY | -44.44% |
| 2020 FY | - CNY | -14.49% |
| 2020 Q4 | -2.11 Million CNY | -123.31% |
| 2020 Q3 | 9.08 Million CNY | -69.5% |
| 2019 Q2 | 19.52 Million CNY | 120.64% |
| 2019 Q1 | 8.84 Million CNY | -69.39% |
| 2019 FY | - CNY | -18.04% |
| 2019 Q4 | 29.6 Million CNY | 160.2% |
| 2019 Q3 | 11.37 Million CNY | -41.74% |
| 2018 Q4 | 28.91 Million CNY | 34.47% |
| 2018 FY | - CNY | -8.84% |
| 2018 Q1 | 23.15 Million CNY | 29.75% |
| 2018 Q2 | 26.44 Million CNY | 14.18% |
| 2018 Q3 | 21.5 Million CNY | -18.69% |
| 2017 Q1 | 30.76 Million CNY | 61.58% |
| 2017 FY | - CNY | -8.32% |
| 2017 Q3 | 28.68 Million CNY | 12.51% |
| 2017 Q4 | 17.84 Million CNY | -37.77% |
| 2017 Q2 | 25.49 Million CNY | -17.13% |
| 2016 Q4 | 19.03 Million CNY | -13.44% |
| 2016 Q3 | 21.99 Million CNY | -39.2% |
| 2016 Q1 | 37.25 Million CNY | 0.0% |
| 2016 Q2 | 36.17 Million CNY | -2.89% |
| 2016 FY | - CNY | 8.95% |
| 2015 FY | - CNY | 74.21% |
| 2014 FY | - CNY | 76.04% |
| 2013 FY | - CNY | -37.18% |
| 2012 FY | - CNY | 0.0% |